The effect of Ivacaftor in CF patients with a class III mutatio
Completed
- Conditions
- Cystic Fibrosis (CF)
- Registration Number
- NL-OMON26309
- Lead Sponsor
- niversity Medical Center Utrecht (UMCU)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
• CFTR genotype compound/ S1251N
• Already had a rectal biopsy to produce an organoid
Exclusion Criteria
• Use of curcumin and or genistein at start or within two weeks prior to start of the study;
• Inability to follow instructions of the investigator.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method